OTTOKIND UK Footer

How to justify ergonomic workstations to your management team

You already know the workstations need changing. The benches are the wrong height for half the workforce, MSD-related absence is a recurring cost, and an HSE inspection is a risk you are not comfortable with. The obstacle is not the decision itself — it is getting sign-off. This guide sets out the arguments your finance director and MD will respond to, with the numbers to back them up.

Why the internal business case is hard to make

Ergonomic workstations are a straightforward purchase decision in terms of benefit, but they sit in an awkward space when it comes to internal approval. The cost is visible and upfront. The benefits — reduced absence, lower liability, better output — are distributed across time and across departments. Finance sees a capital line item. HR and operations see the payback. Getting both sides to engage at the same time is the challenge.

The other difficulty is that MSDs develop slowly. Workers adapt to poor workstations over months and years. Symptoms are underreported until they become serious. By the time absence costs become visible on a spreadsheet, the damage has already been done — and the employer may already have a liability they are not aware of.

The arguments below are designed to bridge that gap. Use whichever of them is most relevant to the decision-maker you are presenting to.

The compliance argument

The Manual Handling Operations Regulations 1992 place a legal duty on employers to reduce musculoskeletal injury risk to the lowest level reasonably practicable. Where a risk assessment identifies that workers are operating at the wrong height, and an engineering solution exists that would address it, that solution is likely to be considered reasonably practicable by an HSE inspector.

The HSE launched a targeted inspection campaign in 2025 specifically focused on manual handling in manufacturing and construction. Inspectors are actively visiting sites. If your risk assessment has identified workstation-related MSD risk and no engineering controls have been implemented, you are exposed to:

  • An HSE improvement notice requiring action within 21 days.
  • Prosecution and unlimited fines if the notice is not complied with.
  • Civil claims from workers who develop MSDs, where the improvement notice makes it very difficult to argue you were unaware of the risk.

For a finance director who responds to risk management arguments: the cost of a workstation upgrade is known and finite. The cost of an HSE prosecution or a civil MSD claim is not.

The absence cost argument

UK businesses lost 7.1 million working days to work-related musculoskeletal disorders in the most recent HSE statistics. Assembly and production environments account for a disproportionate share because workers spend shifts at benches set for the equipment rather than for the person doing the work.

MSD-related absences are not short. The average spell is measured in days and weeks, not hours. Each absence costs the employer in direct terms (statutory sick pay or contractual sick pay, temporary cover, management time) and in indirect terms (reduced output during the period before the worker takes leave, quality and error impact, and retraining costs if the worker does not return).

A conservative cost calculation:

  • One MSD-related absence per year per production area, lasting three weeks.
  • Direct absence cost at average UK manufacturing wage rates: approximately £1,500 to £2,000.
  • Temporary cover or overtime premium: add 50%.
  • Total direct cost per incident: £2,250 to £3,000, before management time and quality impact.

If your site has 10 assembly workers on fixed-height benches and one MSD absence per year is a realistic expectation, the annual cost is in the range of £2,500 to £3,000. A height-adjustable workstation costs £2,500 to £4,000. The payback period is one to two years on absence prevention alone, before accounting for tax relief or productivity gain.

The productivity argument

Fatigue degrades performance. A worker operating at the wrong bench height for a full shift tires faster, makes more errors and produces less consistent output. The postural strain of working stooped over a low bench, or with shoulders raised at a high one, increases muscular load. As that load accumulates across a shift, concentration falls and fine motor performance declines.

A study published in the Journal of Occupational Rehabilitation found that assembly workers using height-adjustable workstations reported significantly lower discomfort and sustained better output quality across the second half of a shift compared to those on fixed-height benches.

For a production director: if your most fatiguing operations are in the second half of the shift, adjusting the working height reduces that fatigue. If your quality failures cluster at the end of shift, ergonomics is worth investigating as a contributing factor. A height-adjustable workstation costs roughly the same as one quality-related return or rework event per year in most assembly environments.

The lean and standard work argument

Height-adjustable workstations are a lean tool as well as a compliance investment. A modular workstation with a fixed component layout, defined reach zones and preset working height enforces standard work. Every operator starts from the same position, uses the same tools in the same locations, and follows the same method. Method variation — one of the primary sources of quality inconsistency in assembly environments — is reduced by design.

For sites running 5S programmes, the modular superstructure supports shadow boarding, visual management and colour-coded storage directly. The workstation becomes part of the 5S implementation rather than an obstacle to it.

The pitch to a lean director: a height-adjustable workstation with a configured superstructure standardises the workstation itself as a production asset, with defined inputs, defined outputs and a repeatable setup that does not change between operators.

The tax argument

OTTOKIND workstations qualify as plant and machinery under the Annual Investment Allowance. This means 100% of the purchase cost is deductible from taxable profits in the year of purchase — not depreciated over several years. For a business on 25% corporation tax, HMRC contributes a quarter of the cost.

A £20,000 investment in workstation upgrades costs £15,000 after tax relief at a 25% rate. For a business approaching its financial year-end, purchasing before that date captures the full relief in the current period. This reframes the decision from a spending decision to a timing decision: if the purchase is going to happen in the next 12 months, buying before year-end captures tax relief that would otherwise be deferred.

Speak to your accountant to confirm the position for your specific entity and tax year before committing.

A worked example

This example uses conservative assumptions that a finance director can verify independently.

  • Investment: Five OTTOKIND electric height-adjustable workstations at £3,500 each: £17,500.
  • AIA tax relief at 25%: £4,375. Net cost after tax: £13,125.
  • MSD absences prevented per year: Conservative assumption of one across the five workstations. Direct cost per absence (three weeks): £2,500.
  • Payback on absence prevention alone: £13,125 ÷ £2,500 = approximately 5.3 years.
  • Add productivity improvement of 1% throughput across five stations: value depends on your margin and volume, but is material at most manufacturing wage rates.
  • Add compliance risk avoided: An HSE prosecution can cost tens of thousands in fines and legal fees. Even a low probability of this outcome has a measurable expected cost.

On a combined basis — absence, productivity and compliance risk — the payback period is typically two to three years for a production environment with genuine MSD exposure. Use the net cost after tax relief as the investment figure in any formal appraisal.

What to include in your approval request

When you submit the business case for sign-off, include:

  • The relevant section of your current risk assessment, confirming the MSD risk has been identified.
  • A three-year absence cost estimate based on your site’s actual records, or a conservative industry average.
  • The AIA tax treatment, confirmed by your accountant.
  • A specification from DRH KIND covering the exact equipment, load ratings, height range and configuration for your tasks — this gives you a document to attach to the approval request rather than a brochure.
  • A delivery and installation timeline that fits within your financial year if year-end tax relief is part of the case.

Common questions about making the business case

Start with absence costs — they are the most directly measurable. Pull your last two to three years of MSD-related absence records if available. Apply your wage rates and sick pay obligations to calculate the direct cost per absence, then multiply by your realistic annual frequency. Add AIA tax relief at your corporation tax rate, and you have the core of a credible ROI calculation. We can help you structure this in a call.
The compliance argument is usually the most persuasive with a sceptical audience, because it reframes the decision as risk management rather than welfare spending. An HSE improvement notice requires action within 21 days and failure to comply is a criminal offence. Once your risk assessment has identified the problem, the question is not whether to act but when. Acting before an inspector visits is significantly cheaper than acting after.
Yes, significantly. Worker reports of musculoskeletal symptoms indicate that exposure is accumulating. If those reports are documented — in return-to-work interviews or occupational health referrals — they create a paper trail that makes it harder to argue the employer was unaware of the risk. The appropriate response is to treat the reports as a trigger for action, which is both the legally correct response and the one most likely to prevent a civil claim.
The HSE guidance is clear that the duty is to engineer out the risk, not to train workers to work around it. Where a bench is too low or too high, no amount of posture training removes the biomechanical load — it only makes workers more aware of a problem they cannot solve. Training is required alongside engineering controls, not instead of them.
Yes. Phased purchasing is common — prioritising the highest-risk or highest-volume stations first. Each phase qualifies separately for AIA in the year of purchase. Starting with the stations where your risk assessment identifies the highest exposure gives you the greatest risk reduction per pound spent and a defensible audit trail.
OTTOKIND workstations are typically available within four to six weeks for standard configurations. A specification can be completed in one call, and installation typically takes one day per unit. If you are working to an HSE notice deadline or a financial year-end, tell us at the start of the call and we will work to that timeline.